vs

Side-by-side financial comparison of Amber International Holding Ltd (AMBR) and PAVmed Inc. (PAVM). Click either name above to swap in a different company.

Amber International Holding Ltd is the larger business by last-quarter revenue ($1.9M vs $996.0K, roughly 1.9× PAVmed Inc.). PAVmed Inc. runs the higher net margin — 6465.8% vs 87.5%, a 6378.2% gap on every dollar of revenue.

Amber Road, Inc. (NYSE: AMBR) was a US-based software company specializing in Global Trade Management (GTM) solutions. It was acquired by E2open in 2019.

PAVmed Inc. is a commercial-stage medical technology company that designs, develops and commercializes innovative diagnostic and therapeutic medical products. Its portfolio covers point-of-care diagnostics, interventional oncology and gastroenterology solutions, primarily serving healthcare providers and patients across the United States.

AMBR vs PAVM — Head-to-Head

Bigger by revenue
AMBR
AMBR
1.9× larger
AMBR
$1.9M
$996.0K
PAVM
Higher net margin
PAVM
PAVM
6378.2% more per $
PAVM
6465.8%
87.5%
AMBR

Income Statement — Q2 FY2025 vs Q3 FY2024

Metric
AMBR
AMBR
PAVM
PAVM
Revenue
$1.9M
$996.0K
Net Profit
$1.6M
$64.4M
Gross Margin
39.9%
-38.7%
Operating Margin
1.5%
-1162.4%
Net Margin
87.5%
6465.8%
Revenue YoY
25.9%
Net Profit YoY
464.4%
EPS (diluted)
$0.02
$1.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMBR
AMBR
PAVM
PAVM
Q2 25
$1.9M
Q3 24
$996.0K
Q2 24
$979.0K
Q1 24
$1.0M
Q4 23
$1.0M
Q3 23
$791.0K
Q2 23
$166.0K
Q1 23
$446.0K
Net Profit
AMBR
AMBR
PAVM
PAVM
Q2 25
$1.6M
Q3 24
$64.4M
Q2 24
$-10.8M
Q1 24
$-15.2M
Q4 23
$-14.0M
Q3 23
$-17.7M
Q2 23
$-14.5M
Q1 23
$-17.9M
Gross Margin
AMBR
AMBR
PAVM
PAVM
Q2 25
39.9%
Q3 24
-38.7%
Q2 24
-70.2%
Q1 24
-72.7%
Q4 23
-53.5%
Q3 23
-124.9%
Q2 23
-915.1%
Q1 23
-201.8%
Operating Margin
AMBR
AMBR
PAVM
PAVM
Q2 25
1.5%
Q3 24
-1162.4%
Q2 24
-1397.8%
Q1 24
-1389.7%
Q4 23
-1561.7%
Q3 23
-1963.1%
Q2 23
-9930.1%
Q1 23
-4574.2%
Net Margin
AMBR
AMBR
PAVM
PAVM
Q2 25
87.5%
Q3 24
6465.8%
Q2 24
-1105.9%
Q1 24
-1506.1%
Q4 23
-1338.0%
Q3 23
-2234.0%
Q2 23
-8757.2%
Q1 23
-4020.4%
EPS (diluted)
AMBR
AMBR
PAVM
PAVM
Q2 25
$0.02
Q3 24
$1.44
Q2 24
$-1.19
Q1 24
$-2.62
Q4 23
$-1.90
Q3 23
$-2.38
Q2 23
$-2.10
Q1 23
$-2.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMBR
AMBR
PAVM
PAVM
Cash + ST InvestmentsLiquidity on hand
$25.8M
$765.0K
Total DebtLower is stronger
Stockholders' EquityBook value
$91.3M
$-4.9M
Total Assets
$248.2M
$30.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMBR
AMBR
PAVM
PAVM
Q2 25
$25.8M
Q3 24
$765.0K
Q2 24
$25.5M
Q1 24
$25.5M
Q4 23
$19.6M
Q3 23
$26.4M
Q2 23
$37.2M
Q1 23
$49.3M
Stockholders' Equity
AMBR
AMBR
PAVM
PAVM
Q2 25
$91.3M
Q3 24
$-4.9M
Q2 24
$-73.9M
Q1 24
$-68.8M
Q4 23
$-53.8M
Q3 23
$-43.3M
Q2 23
$-31.5M
Q1 23
$-22.1M
Total Assets
AMBR
AMBR
PAVM
PAVM
Q2 25
$248.2M
Q3 24
$30.6M
Q2 24
$39.4M
Q1 24
$37.3M
Q4 23
$33.1M
Q3 23
$42.0M
Q2 23
$53.7M
Q1 23
$65.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMBR
AMBR
PAVM
PAVM
Operating Cash FlowLast quarter
$-4.1M
$-8.9M
Free Cash FlowOCF − Capex
$-8.9M
FCF MarginFCF / Revenue
-892.5%
Capex IntensityCapex / Revenue
0.6%
Cash ConversionOCF / Net Profit
-2.49×
-0.14×
TTM Free Cash FlowTrailing 4 quarters
$-45.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMBR
AMBR
PAVM
PAVM
Q2 25
$-4.1M
Q3 24
$-8.9M
Q2 24
$-11.7M
Q1 24
$-13.1M
Q4 23
$-11.9M
Q3 23
$-11.1M
Q2 23
$-12.7M
Q1 23
$-16.4M
Free Cash Flow
AMBR
AMBR
PAVM
PAVM
Q2 25
Q3 24
$-8.9M
Q2 24
$-11.7M
Q1 24
$-13.2M
Q4 23
$-12.1M
Q3 23
$-11.1M
Q2 23
$-12.7M
Q1 23
$-16.4M
FCF Margin
AMBR
AMBR
PAVM
PAVM
Q2 25
Q3 24
-892.5%
Q2 24
-1190.9%
Q1 24
-1302.1%
Q4 23
-1149.4%
Q3 23
-1404.2%
Q2 23
-7666.3%
Q1 23
-3674.4%
Capex Intensity
AMBR
AMBR
PAVM
PAVM
Q2 25
Q3 24
0.6%
Q2 24
0.3%
Q1 24
4.2%
Q4 23
17.4%
Q3 23
2.3%
Q2 23
9.0%
Q1 23
5.8%
Cash Conversion
AMBR
AMBR
PAVM
PAVM
Q2 25
-2.49×
Q3 24
-0.14×
Q2 24
Q1 24
Q4 23
Q3 23
Q2 23
Q1 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons